Skip to main content

Advertisement

SpringerLink
Log in

Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD)

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The existence of platelet-derived growth factor (PDGF) receptor autoantibodies in systemic sclerosis is conflicting, and such antibodies were also detected in patients with chronic graft-versus-host disease (GvHD) after allogeneic peripheral blood stem cell transplantation (PBSCT). We therefore aimed to screen for PDGF receptor autoantibodies in patients with chronic GvHD.

Patients and methods

We evaluated the existence of PDGF receptor autoantibodies in 39 patients, while 17 patients presented with a limited and 8 patients with an extensive chronic GvHD, respectively. Furthermore, 14 out of 39 patients had no chronic GvHD.

Results

We detected at least low levels of PDGF receptor autoantibodies in nearly all (35 of 39) patients after allogeneic PBSCT. Interestingly, only one of six patients with high levels of PDGF receptor autoantibodies presented with an extensive chronic GvHD, while the remaining six patients had no clinical signs of chronic GvHD. Thus, there was no correlation between the quantitative detection of antibodies directed against the PDGF receptor and the presence or severity of chronic GvHD.

Conclusion

Platelet-derived growth factor receptor autoantibodies could easily be detected in patient sera. Nevertheless, we did not observe any correlation between the presence of PDGF receptor autoantibodies and the severity of chronic GvHD in patients who underwent allogeneic PBSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM (1989) Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 4:247–254

    PubMed  CAS  Google Scholar 

  • Ball LM, Egeler RM (2008) Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 41(Suppl 2):S58–S64

    Article  PubMed  CAS  Google Scholar 

  • Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667–2676

    Article  PubMed  CAS  Google Scholar 

  • Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175–181

    Article  PubMed  CAS  Google Scholar 

  • Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J, Ljungman P (2007) Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 40:1055–1062

    Article  PubMed  CAS  Google Scholar 

  • Chakraverty R, Mackinnon S (2011) Allogeneic transplantation for lymphoma. J Clin Oncol official J Am Soc ClinOncol 29:1855–1863

    Article  Google Scholar 

  • Choi SW, Levine JE, Ferrara JL (2010) Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 30:75–101

    Article  PubMed  Google Scholar 

  • Chu YW, Gress RE (2008) Murine models of chronic graft-versus-host disease: insights and unresolved issues. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 14:365–378

    Article  CAS  Google Scholar 

  • Classen JF, Henrohn D, Rorsman F, Lennartsson J, Lauwerys BR, Wikstrom G, Rorsman C, Lenglez S, Franck-Larsson K, Tomasi JP, Kampe O, Vanthuyne M, Houssiau FA, Demoulin JB (2009) Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 60:1137–1144

    Article  PubMed  CAS  Google Scholar 

  • Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M, Hosing C, Anderlini P, Donato M, Cleary K, Gajewski J, Neumann J, Ippoliti C, Rondon G, Cohen A, Champlin R (2004) Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 10:178–185

    Article  Google Scholar 

  • Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Investig 114:1308–1316

    PubMed  CAS  Google Scholar 

  • Ferrara JL, Reddy P (2006) Pathophysiology of graft-versus-host disease. Semin Hematol 43:3–10

    Article  PubMed  CAS  Google Scholar 

  • Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550–1561

    Article  PubMed  CAS  Google Scholar 

  • Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 11:945–956

    Article  Google Scholar 

  • Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100:415–419

    Article  PubMed  CAS  Google Scholar 

  • George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K (2010) Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis official J Transplant Soc 12:322–329

    Article  CAS  Google Scholar 

  • Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F (2009) Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:1288–1295

    Article  CAS  Google Scholar 

  • Kier P, Penner E, Bakos S, Kalhs P, Lechner K, Volc-Platzer B, Wesierska-Gadek J, Sauermann G, Gadner H, Emminger-Schmidmeier W et al (1990) Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow Transplant 6:93–96

    PubMed  CAS  Google Scholar 

  • Leder C, Ortler S, Seggewiss R, Einsele H, Wiendl H (2007) Modulation of T-effector function by imatinib at the level of cytokine secretion. Exp Hematol 35:1266–1271

    Article  PubMed  CAS  Google Scholar 

  • Lister J, Messner H, Keystone E, Miller R, Fritzler MJ (1987) Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 24:19–23

    PubMed  CAS  Google Scholar 

  • Loizos N, Lariccia L, Weiner J, Griffith H, Boin F, Hummers L, Wigley F, Kussie P (2009) Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 60:1145–1151

    Article  PubMed  CAS  Google Scholar 

  • Magro L, Mohty M, Catteau B, Coiteux V, Chevallier P, Terriou L, Jouet JP, Yakoub-Agha I (2009) Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 114:719–722

    Article  PubMed  CAS  Google Scholar 

  • Markova B, Herrlich P, Ronnstrand L, Bohmer FD (2003) Identification of protein tyrosine phosphatases associating with the PDGF receptor. Biochemistry 42:2691–2699

    Article  PubMed  CAS  Google Scholar 

  • Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, Maris MB, Storb R (2003) Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102:756–762

    Article  PubMed  CAS  Google Scholar 

  • Olivieri A, Locatelli F, Zecca M, Sanna A, Cimminiello M, Raimondi R, Gini G, Mordini N, Balduzzi A, Leoni P, Gabrielli A, Bacigalupo A (2009) Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 114:709–718

    Article  PubMed  CAS  Google Scholar 

  • Osumi T, Miharu M, Tanaka R, Du W, Takahashi T, Shimada H (2012) Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD. Bone Marrow Transplant 47:139–140

    Article  PubMed  CAS  Google Scholar 

  • Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S, Jagasia M, Lee SJ (2011) Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 117:4651–4657

    Article  PubMed  CAS  Google Scholar 

  • Remberger M, Ackefors M, Berglund S, Blennow O, Dahllof G, Dlugosz A, Garming-Legert K, Gertow J, Gustafsson B, Hassan M, Hassan Z, Hauzenberger D, Hagglund H, Karlsson H, Klingspor L, Kumlien G, Le Blanc K, Ljungman P, Machaczka M, Malmberg KJ, Marschall HU, Mattsson J, Olsson R, Omazic B, Sairafi D, Schaffer M, Svahn BM, Svenberg P, Swartling L, Szakos A, Uhlin M, Uzunel M, Watz E, Wernerson A, Wikman A, Wikstrom AC, Winiarski J, Ringden O (2011) Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 17:1688–1697

    Article  Google Scholar 

  • Rowe JM (2011) Interpreting data on transplant selection and outcome in adult acute lymphoblastic leukemia (ALL). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17:S76–S83

    Article  Google Scholar 

  • Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756–763

    PubMed  CAS  Google Scholar 

  • Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T et al (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250–259

    PubMed  CAS  Google Scholar 

  • Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, Moroncini G, Bacigalupo A, Leoni P, Avvedimento EV, Gabrielli A (2007) Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 110:237–241

    Article  PubMed  CAS  Google Scholar 

  • Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E (2011) Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 17:1–17

    Article  Google Scholar 

  • Zerr P, Distler A, Palumbo-Zerr K, Tomcik M, Vollath S, Dees C, Egberts F, Tinazzi I, Del Galdo F, Distler O, Schett G, Spriewald BM, Distler JH (2012) Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease. Am J Pathol 181:1672–1680

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Deutsche Krebshilfe foundation (Az. 108868).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Erlanger Allee 101, 07740, Jena, Germany

    Baerbel Spies-Weisshart, Kristina Schilling, Andreas Hochhaus, Herbert G. Sayer & Sebastian Scholl

  2. Center for Molecular Biomedicine, Institute of Molecular Cell Biology, Universitätsklinikum Jena, Jena, Germany

    Frank Böhmer

Authors
  1. Baerbel Spies-Weisshart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristina Schilling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frank Böhmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreas Hochhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Herbert G. Sayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sebastian Scholl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Scholl.

Additional information

Herbert G. Sayer and Sebastian Scholl contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spies-Weisshart, B., Schilling, K., Böhmer, F. et al. Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD). J Cancer Res Clin Oncol 139, 1397–1404 (2013). https://doi.org/10.1007/s00432-013-1451-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-013-1451-z

Keywords

Search

Navigation